Literature DB >> 9474146

Treatment of interstitial cystitis: comparison of subtrigonal and supratrigonal cystectomy combined with orthotopic bladder substitution.

J F Linn1, M Hohenfellner, S Roth, S E Dahms, R Stein, L Hertle, J W Thüroff, R Hohenfellner.   

Abstract

PURPOSE: We retrospectively evaluate the outcome of interstitial cystitis treated with subtrigonal or supratrigonal cystectomy and orthotopic bladder substitution.
MATERIALS AND METHODS: Of 22 women and 1 man a mean of 51 years old with interstitial cystitis refractory to conservative therapy 17 were treated with subtrigonal cystectomy and ureteral reimplantation (group 1), and 6 were treated with supratrigonal cystectomy directly above the ureteral orifices (group 2). Both groups underwent orthotopic bladder substitution with an ileocecal pouch (Mainz pouch I).
RESULTS: Postoperatively functional capacity significantly increased from a mean plus or minus standard error of mean 46 +/- 5 to 346 +/- 57 ml. in group 1 and 34 +/- 61 to 319 +/- 29 ml. in group 2 (p < 0.001). Daytime and nighttime urinary frequency significantly decreased from 24 +/- 2 to 8 +/- 1 and 7 +/- 1 to 2 +/- 1 ml., respectively, in group 1 and 28 +/- 2 to 6 +/- 1 and 6 +/- 1 to 1 +/- 1 ml., respectively, in group 2 (p < 0.001). At a mean followup of 93.9 months 14 patients in group 1 (82%) are completely symptom-free, and 1 has tolerable residual urinary urgency and suprapubic pain. At a mean followup of 31.5 months all group 2 patients are symptom-free and void spontaneously, whereas 41% of the group 1 patients require self-catheterization after subtrigonal cystectomy.
CONCLUSIONS: For interstitial cystitis refractory to conservative treatment subtotal cystectomy with orthotopic bladder substitution with the ileocecal pouch (Mainz pouch I) is a valid therapeutic option. In this series supratrigonal and subtrigonal cystectomy resulted in similar relief of symptoms but the former appears to provide better functional bladder rehabilitation.

Entities:  

Mesh:

Year:  1998        PMID: 9474146     DOI: 10.1016/s0022-5347(01)63726-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

Review 1.  [Interstitial cystitis : Diagnosis and pharmacological and surgical therapy].

Authors:  A Gonsior; J Neuhaus; L C Horn; T Bschleipfer; J-U Stolzenburg
Journal:  Urologe A       Date:  2017-06       Impact factor: 0.639

Review 2.  Improvements in safety and recovery following cystectomy: reassessing the role of pre-operative bowel preparation and interventions to speed return of post-operative bowel function.

Authors:  Harras B Zaid; Samuel D Kaffenberger; Sam S Chang
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

Review 3.  Current best practice in the management of cystitis and pelvic pain.

Authors:  Jayne Louise Douglas-Moore; Jonathan Goddard
Journal:  Ther Adv Urol       Date:  2017-10-25

4.  CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Ashley Cox; Nicole Golda; Genevieve Nadeau; J Curtis Nickel; Lesley Carr; Jacques Corcos; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

5.  Long-term outcomes of ulcerative interstitial cystitis after complete transurethral resection with therapeutic hydrodistention.

Authors:  Sang Wook Lee; Woong Bin Kim; Kwang Woo Lee; Jun Mo Kim; Jae Heon Kim; Ji Eun Moon; Si Hyun Kim; Young Ho Kim
Journal:  Int Urol Nephrol       Date:  2020-09-14       Impact factor: 2.370

6.  Effect of transurethral resection with hydrodistention for the treatment of ulcerative interstitial cystitis.

Authors:  Eui Sang Lee; Sang Wook Lee; Kwang Woo Lee; Jun Mo Kim; Young Ho Kim; Min Eui Kim
Journal:  Korean J Urol       Date:  2013-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.